TCL Archive Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds September 26, 2003
TCL Archive CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments April 6, 1990
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013